Blueprint Medicines Corp reports results for the quarter ended December 31 - Earnings Summary

Blueprint Medicines

13/02/2025 15:14

* Blueprint Medicines Corp  BPMC.OQ  reported a quarterly
adjusted
loss of 79 cents​​ per share for the quarter ended December 31,
higher than the same quarter last year, when the company
reported EPS of $-1.82.  The mean expectation of twenty analysts
for the quarter was for a loss of 70 cents per share. Wall
Street expected results to range from $-1.24 to -51 cents per
share.
    * Revenue rose 103.4% to $146.37 million from a year ago;
analysts
expected $145.84 million. 
    * Blueprint Medicines Corp's reported EPS for the quarter
was a
loss of 79 cents​.
    * The company reported a quarterly loss of $49.96 million.
    * Blueprint Medicines Corp shares had risen by 18.7% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 0.9%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 14 "strong buy" or "buy," 5
"hold" and 1 "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Blueprint
Medicines Corp is $128.50 
This summary was machine generated from LSEG data February 13 at
03:14 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2024      -0.70          -0.79          Missed
 Sep. 30 2024      -0.97          -0.89          Beat
 Jun. 30 2024      -1.29          -0.80          Beat
 Mar. 31 2024      -1.66          -1.32          Beat